Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Amsacrine

X
Drug Profile

Amsacrine

Alternative Names: Amekrin; Amsa P-D; Amsidine; Amsidyl; CI 880; m AMSA; NSC 141549; NSC 156303; NSC 249992; SN 11841

Latest Information Update: 25 Sep 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Auckland Cancer Society Research Centre
  • Class Aminoacridines; Antineoplastics; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Leukaemia

Most Recent Events

  • 18 Apr 2016 ProStrakan is now called Kyowa Kirin International
  • 21 Apr 2011 ProStrakan has been acquired by Kyowa Hakko Kirin
  • 31 Jan 2004 OTL Pharma has been acquired by, and merged into, Strakan

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top